Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ivy Carroll

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2003
Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptorsKabirullah Lutfy, Shoshana Eitan, Camron D Bryant, et al.
Pharmacology, Biochemistry, and Behavior|May 13, 2008
Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeysHeather L Kimmel, S Stevens Negus, Kristin M Wilcox, et al.
Journal of Medicinal Chemistry|May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonistsChad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Journal of Medicinal Chemistry|November 3, 2009
The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuseF Ivy Carroll, Philip Abraham, Paul K Gong, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2018
Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in RatsMichael D Raleigh, Megan Laudenbach, Federico Baruffaldi, et al.
Journal of Medicinal Chemistry|June 21, 2011
Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccinesF Ivy Carroll, Bruce E Blough, Ramakrishna R Pidaparthi, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Journal of Medicinal Chemistry|June 1, 2010
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessationRonald J Lukas, Ana Z Muresan, M Imad Damaj, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2010
Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in miceM Imad Damaj, Sheri D Grabus, Hernan A Navarro, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2003
Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptorsKabirullah Lutfy, Shoshana Eitan, Camron D Bryant, et al.
Pharmacology, Biochemistry, and Behavior|May 13, 2008
Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeysHeather L Kimmel, S Stevens Negus, Kristin M Wilcox, et al.
Journal of Medicinal Chemistry|May 9, 2013
Discovery of N-{4-[(3-hydroxyphenyl)-3-methylpiperazin-1-yl]methyl-2-methylpropyl}-4-phenoxybenzamide analogues as selective kappa opioid receptor antagonistsChad M Kormos, Chunyang Jin, Juan Pablo Cueva, et al.
Journal of Medicinal Chemistry|November 3, 2009
The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuseF Ivy Carroll, Philip Abraham, Paul K Gong, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 15, 2018
Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in RatsMichael D Raleigh, Megan Laudenbach, Federico Baruffaldi, et al.
Journal of Medicinal Chemistry|June 21, 2011
Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccinesF Ivy Carroll, Bruce E Blough, Ramakrishna R Pidaparthi, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Journal of Medicinal Chemistry|June 1, 2010
Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessationRonald J Lukas, Ana Z Muresan, M Imad Damaj, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 26, 2010
Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in miceM Imad Damaj, Sheri D Grabus, Hernan A Navarro, et al.
Pageof 19